176 related articles for article (PubMed ID: 15296960)
1. Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration.
Müller-Goymann CC
Eur J Pharm Biopharm; 2004 Sep; 58(2):343-56. PubMed ID: 15296960
[TBL] [Abstract][Full Text] [Related]
2. [Pharmaceutical applications of the zeta potential--use in characterization of colloidal drug carriers].
Le Roy Boehm AL; Fessi H
J Pharm Belg; 2000; 55(2):40-8. PubMed ID: 10842925
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems.
Uner M
Pharmazie; 2006 May; 61(5):375-86. PubMed ID: 16724531
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical characterization of a reverse micellar solution after loading with different drugs.
Friedrich I; Papantoniou I; Müller-Goymann CC
Pharmazie; 2000 Oct; 55(10):755-8. PubMed ID: 11082837
[TBL] [Abstract][Full Text] [Related]
5. Nanostructured lipid carriers system: recent advances in drug delivery.
Iqbal MA; Md S; Sahni JK; Baboota S; Dang S; Ali J
J Drug Target; 2012 Dec; 20(10):813-30. PubMed ID: 22931500
[TBL] [Abstract][Full Text] [Related]
6. Cryogenic transmission electron microscopy (cryo-TEM) for studying the morphology of colloidal drug delivery systems.
Kuntsche J; Horst JC; Bunjes H
Int J Pharm; 2011 Sep; 417(1-2):120-37. PubMed ID: 21310225
[TBL] [Abstract][Full Text] [Related]
7. Physicochemical characterization of drug nanocarriers.
Manaia EB; Abuçafy MP; Chiari-Andréo BG; Silva BL; Oshiro Junior JA; Chiavacci LA
Int J Nanomedicine; 2017; 12():4991-5011. PubMed ID: 28761340
[TBL] [Abstract][Full Text] [Related]
8. Cetyl palmitate-based NLC for topical delivery of Coenzyme Q(10) - development, physicochemical characterization and in vitro release studies.
Teeranachaideekul V; Souto EB; Junyaprasert VB; Müller RH
Eur J Pharm Biopharm; 2007 Aug; 67(1):141-8. PubMed ID: 17346953
[TBL] [Abstract][Full Text] [Related]
9. Encapsulation, protection, and release of hydrophilic active components: potential and limitations of colloidal delivery systems.
McClements DJ
Adv Colloid Interface Sci; 2015 May; 219():27-53. PubMed ID: 25747522
[TBL] [Abstract][Full Text] [Related]
10. [Compared with colloidal silica and porous silica as baicalin solid dispersion carrier].
Yan HM; Ding DM; Wang J; Sun E; Jia XB; Zhang ZH
Zhongguo Zhong Yao Za Zhi; 2014 Jul; 39(13):2484-8. PubMed ID: 25276968
[TBL] [Abstract][Full Text] [Related]
11. Ethosomes® and transfersomes® containing linoleic acid: physicochemical and technological features of topical drug delivery carriers for the potential treatment of melasma disorders.
Celia C; Cilurzo F; Trapasso E; Cosco D; Fresta M; Paolino D
Biomed Microdevices; 2012 Feb; 14(1):119-30. PubMed ID: 21960035
[TBL] [Abstract][Full Text] [Related]
12. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
13. Lipid vesicles and other colloids as drug carriers on the skin.
Cevc G
Adv Drug Deliv Rev; 2004 Mar; 56(5):675-711. PubMed ID: 15019752
[TBL] [Abstract][Full Text] [Related]
14. Characterization of solidified reverse micellar solutions (SRMS) and production development of SRMS-based nanosuspensions.
Friedrich I; Müller-Goymann CC
Eur J Pharm Biopharm; 2003 Jul; 56(1):111-9. PubMed ID: 12837489
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of colloidal soft nano-carriers for transdermal delivery and bioavailability enhancement of an angiotensin II receptor blocker.
Hathout RM; Elshafeey AH
Eur J Pharm Biopharm; 2012 Oct; 82(2):230-40. PubMed ID: 22820090
[TBL] [Abstract][Full Text] [Related]
16. The formalism of fractal aggregation phenomena of colloidal drug delivery systems.
Pippa N; Demetzos C; Danezis E
J Liposome Res; 2012 Mar; 22(1):55-61. PubMed ID: 21774618
[TBL] [Abstract][Full Text] [Related]
17. Engineering of amphiphilic block copolymers for polymeric micellar drug and gene delivery.
Xiong XB; Falamarzian A; Garg SM; Lavasanifar A
J Control Release; 2011 Oct; 155(2):248-61. PubMed ID: 21621570
[TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization, and evaluation of physicochemical properties of different crystalline forms of ibuprofen.
Khan GM; Jiabi Z
Drug Dev Ind Pharm; 1998 May; 24(5):463-71. PubMed ID: 9876609
[TBL] [Abstract][Full Text] [Related]
19. Characterization of submicron systems via optical methods.
Haskell RJ
J Pharm Sci; 1998 Feb; 87(2):125-9. PubMed ID: 9519143
[TBL] [Abstract][Full Text] [Related]
20. A novel drug delivery system -- Drug crystallization encapsulated liquid crystal emulsion.
Hu J; Ni Z; Zhu H; Li H; Chen Y; Shang Y; Chen D; Liu H
Int J Pharm; 2021 Sep; 607():121007. PubMed ID: 34391854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
